Clinical Trial Update: Long-term Safety Follow-up After Growth Hormone Treatment of Short Children Born Small for Gestational Age [NA]

View source ↗

Summary

Long-term safety follow-up study of growth hormone treatment in children born small for gestational age has terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Short Children Born Small For Gestational Age

Drugs mentioned

• Not specified

Snippet

Sponsor: Sandoz | Conditions: Short Children Born Small for Gestational Age (SGA) | NA | Status: TERMINATED | Results posted: 2019-08-14